S21-311 CCL5-mediated activation of immune adverse reaction in immune check point inhibitor-treated cancer patients An increasing number of cancer patients are now receiving immune checkpoint inhibitors (ICIs), which boost the immune system to attack cancer cells. Sean Wu Patricia Nguyen Han Zhu
S22-100 Monoclonal Antibodies for Targeting the Cardiac Conduction System Stanford scientists developed Cardiac Conduction System (CCS) targeting monoclonal antibodies. Sean Wu William Goodyer
S20-273 Expansion of Human iPSC-derived Cardiomyocytes In Vitro Through Small Molecule Inhibition of Cell-Cell Contact Stanford inventors have identified a treatment regimen that allows expansion of cardiomyocytes (CMs) derived from human induced pluripotent stem cells in vitro. Sean Wu Soah Lee